VKIN yields 247.83% · PFE yields 6.13%● Live data
📍 VKIN pulled ahead of the other in Year 1
Combined, VKIN + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VKIN + PFE for your $10,000?
Viking Energy Group, Inc., an exploration and production company, engages in the acquisition and development of oil and natural gas properties in North America. It manufactures and supplies power generation products, services, and custom energy solutions; clean-tech energy systems, including combined heat and power, tier 4 final diesel, and natural gas industrial engines, solar, wind, and storage; designs and assembles electrical control equipment, such as switch gear, synchronization and paralleling gear, distribution, Bi-fuel, and complete power generation production controls; and clean energy and carbon-capture systems to generate clean electricity. The company also engages in developing, patent pending, electric transmission, and distribution of open conductor detection systems to detect a break in a transmission line, distribution line, or coupling failure. The company owns oil and gas leases in Texas, Louisiana, Mississippi, and Kansas. The company was formerly known as Viking Investments Group, Inc. and changed its name to Viking Energy Group, Inc. in March 2017. Viking Energy Group, Inc. was incorporated in 1989 and is headquartered in Houston, Texas.
Full VKIN Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.